Real‐world efficacy and safety of cannabidiol in developmental and epileptic encephalopathies
Abstract Objective Highly purified cannabidiol (CBD) is approved as adjunctive therapy for seizures associated with Dravet syndrome (DS), Lennox–Gastaut syndrome (LGS), and tuberous sclerosis complex (TSC), although its role in other developmental and epileptic encephalopathies (DEEs) remains unexpl...
में बचाया:
| मुख्य लेखकों: | , , , , , , , , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Wiley
2025-12-01
|
| श्रृंखला: | Epilepsia Open |
| विषय: | |
| ऑनलाइन पहुंच: | https://doi.org/10.1002/epi4.70149 |
| टैग: |
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|
